Publications by authors named "Hasan A Albitar"

Claim this Profile
A
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.
Hanny Al-Samkari, Raj S Kasthuri, Joseph G Parambil, Hasan A Albitar, Yahya A Almodallal

Haematologica· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia.
Hanny Al-Samkari, Hasan A Albitar, Scott E Olitsky, Marianne S Clancy, Vivek N Iyer

Haemophilia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab.
Hasan Ahmad Albitar, Yahya Almodallal, Rick Nishimura, Vivek N Iyer

Mayo Clin Proc Innov Qual Outcomes· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers.
Hanny Al-Samkari, Hasan A Albitar, Scott E Olitsky, Marianne S Clancy, Vivek N Iyer

Orphanet J Rare Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis